January 19, 2026
The anti-aging market size is forecast to grow from USD 84.41 billion in 2026 to USD 137.13 billion by 2035, g...
Read MoreApril 21, 2026
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreApril 21, 2026
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreApril 21, 2026
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreApril 21, 2026
Based on market forecasts, the monoclonal antibodies therapeutics sector will expand from USD 265.17 billion in 2024 to USD 1057.91 billion by 2034, experiencing a CAGR of 14.84%. In 2024, North America led the monoclonal antibody therapeutics market, with human mABs and cancer applications holding the largest shares. Asia Pacific is set for the fa...
April 21, 2026
According to market projections, the isotope sector is expected to grow from USD 6.09 billion in 2024 to USD 14.2 billion by 2034, reflecting a CAGR of 8.84%. In 2024, North America led the global isotope market, while Asia-Pacific is set for the fastest growth. Radioisotopes dominated, but stable isotopes are expected to rise. Diagnostics held the...
April 21, 2026
Market insights predict the global progesterone industry will increase from USD 1.52 billion in 2024 to USD 5.05 billion by 2034, achieving a CAGR of 12.74%. In 2024, North America led the progesterone market, while Asia Pacific is set for the fastest growth. Natural formulations held the largest share, but synthetic ones will grow quickest. Inject...
April 21, 2026
According to market projections, the hormonal replacement therapy sector is expected to grow from USD 24.26 billion in 2024 to USD 46.32 billion by 2034, reflecting a CAGR of 6.68%. In 2024, North America led the hormonal replacement therapy market with a 40% share, while Asia Pacific is set for the fastest growth. Estrogen and progesterone therapy...
April 21, 2026
According to market projections, the global dementia treatments market, valued at USD 18.09 billion in 2024, is anticipated to reach USD 39.16 billion by 2034, growing at a CAGR of 8.03% over the next decade. In 2024, North America led the dementia treatments market (39%), while Asia Pacific is the fastest-growing region. Alzheimer’s disease ...
April 21, 2026
According to market projections, the influenza vaccine sector is expected to grow from USD 8.49 billion in 2024 to USD 16.73 billion by 2034, reflecting a CAGR of 7.02%. In 2024, North America led the influenza vaccine market (53% share), with Asia Pacific set for the fastest growth. Inactivated vaccines dominated and will see the highest CAGR, whi...
April 21, 2026
Based on market forecasts, the monoclonal antibodies in veterinary health sector will expand from USD 1.23 billion in 2024 to USD 6 billion by 2034, experiencing a CAGR of 17.13%. In 2024, North America led the veterinary monoclonal antibodies market with a 44% share, while Asia Pacific is the fastest-growing region. Dogs dominated by animal type, ...
April 21, 2026
According to market projections, the DNA vaccine sector is expected to grow from USD 553.89 million in 2024 to USD 1041.68 million by 2034, reflecting a CAGR of 6.52%. In 2024, North America led the global DNA vaccine market, with Asia-Pacific expected to grow fastest. Oncept dominated by product type, while Apex-IHN is set for notable growth....
April 21, 2026
According to market projections, the pelvic inflammatory disease treatment sector is expected to grow from USD 3.52 billion in 2024 to USD 5.09 billion by 2034, reflecting a CAGR of 3.75%. In 2024, North America led the global pelvic inflammatory disease treatment market, with antibiotic therapy, oral administration, adult women, and hospitals as d...
April 21, 2026
Market insights predict the global cervical cancer treatment industry will increase from USD 8.65 billion in 2024 to USD 14.68 billion by 2034, achieving a CAGR of 5.44%. In 2024, North America led the cervical cancer treatment market, with Europe set for strong growth. Squamous cell carcinoma was the top type, while adenocarcinoma is expected to g...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
